Karel A Hinnen

Summary

Publications

  1. doi request reprint Prostate specific antigen bounce is related to overall survival in prostate brachytherapy
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Int J Radiat Oncol Biol Phys 82:883-8. 2012
  2. doi request reprint Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Radiother Oncol 96:30-3. 2010
  3. doi request reprint Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Int J Radiat Oncol Biol Phys 76:1433-8. 2010
  4. doi request reprint Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients
    Joep G H van Roermund
    Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
    BJU Int 107:1775-9. 2011
  5. doi request reprint The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life
    Ellen M A Roeloffzen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Int J Radiat Oncol Biol Phys 77:1322-8. 2010
  6. doi request reprint Survival after prostate brachytherapy in patients aged 60 years and younger
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands
    BJU Int 107:1906-11. 2011
  7. doi request reprint Prostate brachytherapy and second primary cancer risk: a competitive risk analysis
    Karel A Hinnen
    Department of Radiation Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Clin Oncol 29:4510-5. 2011
  8. doi request reprint Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy
    Joep G H van Roermund
    Department of Urology, University Medical Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands
    BJU Int 105:42-8. 2010
  9. doi request reprint Predictors in the outcome of 125I brachytherapy as monotherapy for prostate cancer
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, PO Box 85500, 3508 GA, The Netherlands
    Expert Rev Anticancer Ther 11:115-23. 2011

Detail Information

Publications9

  1. doi request reprint Prostate specific antigen bounce is related to overall survival in prostate brachytherapy
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Int J Radiat Oncol Biol Phys 82:883-8. 2012
    ..To investigate the association between prostate specific antigen (PSA) bounce and disease outcome after prostate brachytherapy...
  2. doi request reprint Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Radiother Oncol 96:30-3. 2010
    ..To assess clinical outcome in terms of biochemical No evidence of disease (bNED) for patients with stranded seed implants versus loose seed implants in prostate brachytherapy...
  3. doi request reprint Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Int J Radiat Oncol Biol Phys 76:1433-8. 2010
    ..To assess long-term biochemical and survival outcome after permanent prostate brachytherapy (BT)...
  4. doi request reprint Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients
    Joep G H van Roermund
    Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
    BJU Int 107:1775-9. 2011
    ..Prognostic (case series)...
  5. doi request reprint The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life
    Ellen M A Roeloffzen
    Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Int J Radiat Oncol Biol Phys 77:1322-8. 2010
    ....
  6. doi request reprint Survival after prostate brachytherapy in patients aged 60 years and younger
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands
    BJU Int 107:1906-11. 2011
    ..To compare survival after prostate brachytherapy in patients aged ≤60 years with patients aged >60 years...
  7. doi request reprint Prostate brachytherapy and second primary cancer risk: a competitive risk analysis
    Karel A Hinnen
    Department of Radiation Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Clin Oncol 29:4510-5. 2011
    ..To assess the risk of second primary cancer (SPC) after [(125)I]iodine prostate cancer brachytherapy compared with prostatectomy and the general population...
  8. doi request reprint Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy
    Joep G H van Roermund
    Department of Urology, University Medical Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands
    BJU Int 105:42-8. 2010
    ....
  9. doi request reprint Predictors in the outcome of 125I brachytherapy as monotherapy for prostate cancer
    Karel A Hinnen
    Department of Radiation Oncology, University Medical Center Utrecht, PO Box 85500, 3508 GA, The Netherlands
    Expert Rev Anticancer Ther 11:115-23. 2011
    ..For the prediction of outcome after (125)I brachytherapy, as long as the quality of the implant is optimal, only high-risk prostate cancer was found to have a negative impact on outcome...